Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

BACKGROUND: Secondary osteoporosis may occur in patients with rheumatoid arthritis (RA), causing irreversible joint damage and disability. Bisphosphonates, the recently developed bone resorption inhibitors, have demonstrated significant therapeutic effects on senile and postmenopausal osteoporosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jun, Li, Shaohua, Xiao, Lianbo, Ouyang, Guilin, Zheng, Lin, Gu, Yubiao, Gao, Chengxin, Han, Xiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902494/
https://www.ncbi.nlm.nih.gov/pubmed/31823822
http://dx.doi.org/10.1186/s13018-019-1492-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902494/
https://www.ncbi.nlm.nih.gov/pubmed/31823822
http://dx.doi.org/10.1186/s13018-019-1492-3

Ejemplares similares